Tag: stem cell therapy

December 10, 2018

Genetics Outlook 2019: CRISPR Technology Advances

With 2018 coming to a close, here's a look at the biggest genetics trends of the year and what's in...
May 4, 2018

Broadway Announces New President and CEO

Broadway Gold Mining Ltd. (TSXV:BRD) is pleased to announce the appointment of Mr. Thomas A. Smeenk, BA, as President and...
April 19, 2018

FDA Clinical Trial Approval Spikes Hemostemix’s Share Price

The cell-therapy company's share price increased by over 90 percent after the milestone announcement was released on Thursday.
April 10, 2018

Neuralstem Announces First Surgery Completed in Cervical Cohort of Phase 1 Clinical Trial in Patients with Chronic Spinal Cord Injury

Neuralstem (Nasdaq:CUR), a biopharmaceutical company focused on the development of nervous system therapies based on its neural stem cell technology,...
March 26, 2018

TiGenix and Takeda announce Alofisel (darvadstrocel) receives approval to treat complex perianal fistulas in Crohn’s disease in Europe

TiGenix (NASDAQ: TIG) and Takeda Pharmaceutical (TSE: 4502) announced that the European Commission (EC) has approved Alofisel (darvadstrocel), previously Cx601,...
March 15, 2018

Top 10 Stem Cell Companies On The NASDAQ

The global stem cell therapy market is expected to grow at a CAGR of 36.52 percent between 2017 and 2021....
December 7, 2017

CRISPR Therapeutics Submits Clinical Trial Application for a CRISPR Gene-Edited Therapy

CRISPR Therapeutics announced the submission of a clinical trial application for CTX001 in β-thalassemia.